Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) EBT Margin (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed EBT Margin for 5 consecutive years, with 859.97% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT Margin rose 19558.0% year-over-year to 859.97%, compared with a TTM value of 1224.66% through Sep 2025, down 15476.0%, and an annual FY2024 reading of 1058.81%, up 111030.0% over the prior year.
  • EBT Margin was 859.97% for Q3 2025 at Lucid Diagnostics, down from 381.69% in the prior quarter.
  • Across five years, EBT Margin topped out at 4192.52% in Q2 2021 and bottomed at 18880.26% in Q3 2022.
  • Average EBT Margin over 5 years is 3773.79%, with a median of 1471.06% recorded in 2023.
  • The sharpest move saw EBT Margin crashed -1540195bps in 2022, then skyrocketed 1706570bps in 2023.
  • Year by year, EBT Margin stood at 3478.31% in 2021, then plummeted by -283bps to 13328.57% in 2022, then surged by 92bps to 1041.35% in 2023, then increased by 4bps to 1002.69% in 2024, then rose by 14bps to 859.97% in 2025.
  • Business Quant data shows EBT Margin for LUCD at 859.97% in Q3 2025, 381.69% in Q2 2025, and 3249.76% in Q1 2025.